Total Synthesis of Calystegine B4
NaHCO3 (2 mL) and mixture extracted with CH2Cl2 (3ϫ20 mL).
The combined organic extracts were washed with brine (50 mL)
and dried (MgSO4). The crude product was purified by column
chromatography [EtOAc/petroleum ether (10:90 to 20:80)] to give
13 as a colourless oil in 85% yield (379.3 mg, 0.532 mmol). Rf =
0.33 [EtOAc/petroleum ether (30:70)]. LRMS (ESI): m/z (%) =
713.4 (35) [M + H]+, 730.6 (35) [M + NH3]+. HRMS (ESI): m/z =
(m, 5 H, 4ϫ OCH2Ph and 3-H), 4.46 (d, J = 11.5 Hz, 1 H, 1ϫ
OCH2Ph), 4.35 (d, J = 5.5 Hz, 1 H, 7-H), 4.25 (br. s, 3 H, NCH2
and CHOBn), 3.91 (br. s, 1 H, CHOBn), 3.71 (t, J = 5.5 Hz, 1 H,
CHOBn), 2.68 (br. s, 1 H, OH), 1.42 (s, 9 H, 9ϫ CH3) ppm. 13C
NMR (125 MHz, CDCl3): δ = 155.6 (C=O), 139.1 (ArC), 138.5
(ArC), 138.3 (ArC), 137.3 (C-8), 137.1 (ArC), 133.9 (C-1), 128.35
(ArCH), 128.29 (ArCH), 128.26 (ArCH), 128.1 (ArCH), 128.0
(ArCH), 127.9 (ArCH), 127.8 (ArCH), 127.60 (ArCH), 127.55
(ArCH), 127.3 (ArCH), 126.8 (C-2), 126.4 (ArCH), 117.0 (C-9),
714.3810 [M + H]+, calcd. for C46H52NO6 714.3795. IR: ν
=
˜
max
3442, 3027, 2935, 1687, 1450, 1163, 1058 cm–1. [α]2D0 = –22.9 (c =
1.7, CHCl3). 1H NMR (500 MHz, CDCl3): δ = 7.39–7.28 (m, 10 81.6 (CHOBn), 80.6 (CHOBn), 80.4 (CHOBn), 74.4 (OCH2Ph),
H, 10ϫ ArCH), 7.24–7.21 (m, 6 H, 6ϫ ArCH), 7.17 (m, 5 H, 5ϫ 74.3 (OCH2Ph), 73.1 (OCH2Ph), 72.9 (C-7), 60.3 (C-3), 50.6
ArCH), 7.07 (m, 4 H, 4ϫ ArCH), 6.47 (br. m, 1 H, 1-H or 2-H), (NCH2), 28.4 (CH3) ppm.
6.08 (br. m, 1 H, 1-H or 2-H), 4.77 (d, J = 11.5 Hz, 1 H, 1ϫ
16: Rf = 0.36 [EtOAc/petroleum ether (20:80)]. LRMS (ESI): m/z
(%) = 740.7 (43) [M + H]+. HRMS (ESI): m/z = 740.3967 [M +
H]+, calcd. for C H NO 740.3951. IR: ν
= 3476, 3032, 2919,
OCH2Ph), 4.76 (s, 2 H, 2ϫ OCH2Ph), 4.70 (d, J = 5.0 Hz, 1 H,
1ϫ OCH2Ph), 4.67 (d, J = 4.5 Hz, 1 H, 1ϫ OCH2Ph), 4.51 (d, J
= 12.0 Hz, 1 H, 1ϫ OCH2Ph), 4.37 (br. s, 1 H, 3-H), 4.20 (d, J =
15.5 Hz, 2 H, NCH2), 3.99 (d, J = 7.0 Hz, 1 H, CHOBn), 3.84–
3.82 (m, 1 H, 1ϫ 7-H), 3.75 (br. s, 1 H, 1ϫ 7-H), 3.67 (quint, J =
3.5 Hz, 1 H, CHOBn), 1.36 (s, 9 H, 9ϫ CH3) ppm; signal of 1ϫ
CHOBn not seen due to peak broadening. 13C NMR (125 MHz,
CDCl3): δ = 155.4 (C=O), 143.5 (ArC), 138.9 (ArC), 138.7 (ArC),
138.4 (ArC), 137.2 (ArC), 133.5 (poss. C-1), 128.7 (ArCH), 128.5
(ArCH), 128.4 (ArCH), 128.30 (ArCH), 128.26 (ArCH), 128.13
(ArCH), 128.08 (ArCH), 128.0 (ArCH), 127.9 (ArCH), 127.83
(ArCH), 127.75 (ArCH), 127.7 (ArCH), 127.6 (ArCH), 127.2 (poss.
C-2), 126.9 (ArCH), 126.4 (ArCH), 80.3 (CHOBn), 79.9 (CHOBn),
79.3 (CHOBn), 74.6 (OCH2Ph), 73.0 (OCH2Ph), 72.8 (OCH2Ph),
61.5 (C-7), 61.2 (C-3), 51.4 (NCH2), 28.4 (CH3) ppm.
˜
max
48 54
6
1685, 1450, 1162, 1063 cm–1. [α]2D4 = –34.3 (c = 0.53, CHCl3). 1H
NMR (500 MHz, CDCl3): δ = 7.30–7.02 (m, 25 H, 25ϫ ArCH),
6.52 (br. s, 1 H, 1-H or 2-H), 6.16 (br. s, 1 H, 1-H or 2-H), 5.97 (t,
J = 11.5 Hz, 1 H, 8-H), 5.40 (d, J = 17.0 Hz, 1 H, 1ϫ 9-H), 5.21
(d, J = 8.5 Hz, 1 H, 1ϫ 9-H), 4.86 (d, J = 9.5 Hz, 1 H, 1ϫ
OCH2Ph), 4.78 (m, 2 H, 2ϫ OCH2Ph), 4.71 (d, J = 11.0 Hz, 1 H,
1ϫ OCH2Ph), 4.62 (dd, J = 11.0, 2.0 Hz, 1 H, 1ϫ OCH2Ph), 4.57
(m, 1 H, 3-H), 4.49 (m, 1 H, 1ϫ OCH2Ph), 4.40 (m, 1 H, 7-H),
4.27 (d, J = 13.0 Hz, 2 H, 2ϫ NCH2), 4.06 (s, 1 H, CHOBn), 3.68
(br. s, 1 H, CHOBn), 2.84 (br. s, 1 H, OH), 1.36 (s, 9 H, 9ϫ CH3)
ppm; signal of 1ϫ CHOBn not seen due to peak broadening. 13C
NMR (125 MHz, CDCl3): δ = 155.7 (C=O), 138.8 (C-8), 137.2
(ArC), 134.9 (ArC), 133.6 (poss. C-1), 128.3 (ArCH), 128.2
(ArCH), 128.0 (ArCH), 127.7 (ArCH), 127.5 (ArCH), 127.1
(ArCH), 126.4 (ArCH), 115.3 (C-9), 82.0 (CHOBn), 81.0
(CHOBn), 75.2 (OCH2Ph), 74.6 (OCH2Ph), 73.0 (OCH2Ph), 71.8
(C-7), 60.7 (C-3), 51.1 (NCH2), 28.4 (CH3) ppm; several signals
were not seen due to extensive peak broadening.
tert-Butyl (1E,3R,4R,5R,6S)-N-Benzyl-4,5,6-tris(benzyloxy)-7-oxo-
1-phenylhept-1-en-3-ylcarbamate (14), tert-Butyl (1E,3R,4R,5R,
6R,7R)-N-Benzyl-4,5,6-tris(benzyloxy)-7-hydroxy-1-phenylnona-
1,8-dien-3-ylcarbamate (15) and tert-Butyl N-Benzyl-(1E,3R,4R,
5R,6R,7S)-4,5,6-tris(benzyloxy)-7-hydroxy-1-phenylnona-1,8-dien-
3-ylcarbamate (16): To a solution of 13 (1.005 g, 1.410 mmol) in dry
CH2Cl2 (47.2 mL) was added Dess–Martin periodinane (897.1 mg,
2.115 mmol), and the mixture was stirred at room temp. under N2
for 1.5 h. The mixture was then diluted with diethyl ether (18 mL)
and the reaction quenched with saturated NaHCO3 solution
(18 mL) and sodium thiosulfate (5.5 g). The product was extracted
with diethyl ether (3ϫ60 mL), and the combined organic extracts
were washed with saturated NaHCO3 solution (100 mL), then H2O
(100 mL) and dried (MgSO4). The solvent was removed to give the
crude aldehyde 14 as a yellow oil in 91% yield (916.5 mg,
tert-Butyl (1R,2Z,4R,5R,6R,7R)-N-Benzyl-5,6,7-tris(benzyloxy)-4-
hydroxycyclohept-2-enylcarbamate (17): To
a solution of 15
(22.2 mg, 0.030 mmol) in anhydrous CH2Cl2 (1.47 mL) was added
10 mol-% Grubbs’ 2nd generation catalyst (2.55 mg, 0.003 mmol).
The mixture was subjected to microwave irradiation in a sealed
tube in a CEM Discover microwave reactor at 90 °C, 100 W and
100 psi for 2 h. The solvent was then removed and the product
purified by column chromatography [EtOAc/petroleum ether (5:95
to 15:85)] to give 11 as a colourless oil in 77% yield (14.7 mg,
0.023 mmol). Rf = 0.20 [EtOAc/petroleum ether (20:80)]. LRMS
(ESI): m/z (%) = 636 (100) [M + H]+. HRMS (ESI): m/z = 636.3339
1.289 mmol). Then, to
a solution of crude 14 (916.5 mg,
1.289 mmol) in dry THF (18.1 mL) was added vinylmagnesium
bromide (1.0 THF, 1.93 mL, 1.934 mmol) at 0 °C under N2. The
mixture was then warmed to room temp. and stirred for 2 h before
quenching the reaction with saturated ammonium chloride solution
(12 mL); CH2Cl2 (12 mL) was added, and the product was ex-
tracted with CH2Cl2 (3ϫ50 mL) and dried (MgSO4). The crude
products were purified and separated by column chromatography
[EtOAc/petroleum ether (5:95 to 10:90)] to give 15 as a colourless
oil in 29.4% yield (306.0 mg, 0.414 mmol) and 16 as a colourless
oil in 23.4% (243.8 mg, 0.330 mmol).
[M + H]+, calcd. for C H NO 636.3325. IR: ν
= 3432, 2960,
˜
max
40 46
6
2919, 1685, 1455, 1261, 1062 cm–1. [α]2D3 = –55.2 (c = 1.47, CHCl3).
1H NMR (500 MHz, CDCl3): δ = 7.36–7.24 (m, 16 H, 16ϫ ArCH),
7.17 (t, J = 7.0 Hz, 2 H, 2ϫ ArCH), 7.12 (m, 2 H, 2ϫ ArCH),
5.70 (d, J = 12.0 Hz, 1 H, 2-H or 3-H), 5.33 (d, J = 11.0 Hz, 1 H,
2-H or 3-H), 5.03 (br. s, 2 H, 1-H and 4β-H), 4.93 (d, J = 11.5 Hz,
1 H, 1ϫ OCH2Ph), 4.84 (d, J = 11.5 Hz, 1 H, 1ϫ OCH2Ph), 4.74
(d, J = 11.5 Hz, 1 H, 1ϫ OCH2Ph-6), 4.63 (m, 1 H, 1ϫ OCH2Ph),
4.61 (t, J = 4.0 Hz, 1 H, 1ϫ OCH2Ph), 4.57 (d, J = 11.5 Hz, 1 H,
1ϫ OCH2Ph-6), 4.50 (br. s, 1 H, 5-H or 7-H), 4.49 (d, J = 13.0 Hz,
1 H, 1ϫ NCH2), 4.25 (br. s, 1 H, 1ϫ NCH2), 4.06 (t, J = 4.5 Hz,
1 H, 5-H or 7-H), 3.74 (d, J = 6.0 Hz, 1 H, 6-H), 2.78 (d, J =
9.5 Hz, 1 H, OH), 1.31 (s, 9 H, 9ϫ CH3) ppm. 13C NMR
(125 MHz, CDCl3): δ = 155.7 (C=O), 140.7 (ArC), 138.2 (ArC),
15: Rf = 0.29 [EtOAc/petroleum ether (20:80)]. LRMS (ESI): m/z
(%) = 740.7 (41) [M + H]+. HRMS (ESI): m/z = 740.3972 [M +
H]+, calcd. for C H NO 740.3951. IR: ν
= 3032, 2920, 1690,
˜
max
48 54
6
1450, 1368, 1162, 1067 cm–1. [α]2D4 = –7.13 (c = 0.44, CHCl3). 1H
NMR (500 MHz, CDCl3): δ = 7.35–7.23 (m, 11 H, 11ϫ ArCH),
7.24–7.17 (m, 11 H, 11ϫ ArCH), 7.11 (m, 3 H, 3ϫ ArCH), 6.45 136.1 (C-2 or C-3), 128.5 (ArCH), 128.4 (ArCH), 128.3 (ArCH),
(br. s, 1 H, 2-H), 6.18 (br. s, 1 H, 1-H), 6.02 (ddd, J = 6.5 Hz, 1 H, 128.0 (ArCH), 127.9 (ArCH), 127.75 (ArCH), 127.67 (ArCH),
8-H), 5.37 (d, J = 17.5 Hz, 1 H, 1ϫ 9-H), 5.25 (d, J = 10.0 Hz, 1 126.6 (ArCH), 126.2 (ArCH), 126.1 (ArCH), 125.4 (C-2 or C-3),
H, 1ϫ 9-H), 4.83 (d, J = 11.0 Hz, 1 H, 1ϫ OCH2Ph), 4.72–4.63
84.7 (C-5 or C-7), 84.3 (C-6), 80.1 [C(CH3)3], 78.9 (C-5 or C-7),
Eur. J. Org. Chem. 2010, 3337–3344
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3341